RANDAL J KIRK Insider Trading Transactions
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
Latest Insider Trading Transactions of RANDAL J KIRK
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 29 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Option Exercise | A | 0.00 | 32,425 | 0 | 32,425 | |
Mar 29 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Option Exercise | A | 5.65 | 44,214 | 249,809 | 44,214 | |
Mar 29 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Grant | A | 7.71 | 12,970 | 99,999 | 18,329,996 | 18.3 M to 18.3 M (+0.07 %) |
Mar 12 2021 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Option Exercise | A | 6.72 | 2,500 | 16,800 | 2,500 | |
Jan 05 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Option Exercise | M | 0.00 | 3,444 | 0 | 6,887 | |
Jan 05 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | M | 0.00 | 3,444 | 0 | 18,317,026 | 18.3 M to 18.3 M (+0.02 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 8,100 | 0 | 1,260,538 | 1.3 M to 1.3 M (+0.65 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 691,929 | 0 | 691,929 | 0 to 691.9 K |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 16,200 | 0 | 2,976,063 | 3 M to 3 M (+0.55 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,383,857 | 0 | 2,959,863 | 1.6 M to 3 M (+87.81 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,383,858 | 0 | 1,383,858 | 0 to 1.4 M |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 16,200 | 0 | 1,592,206 | 1.6 M to 1.6 M (+1.03 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,620 | 0 | 444,007 | 442.4 K to 444 K (+0.37 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 222,264 | 0 | 442,387 | 220.1 K to 442.4 K (+100.97 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 8,100 | 0 | 1,589,531 | 1.6 M to 1.6 M (+0.51 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 10,125 | 0 | 1,572,208 | 1.6 M to 1.6 M (+0.65 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,835 | 0 | 561,872 | 559 K to 561.9 K (+0.51 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 123,476 | 0 | 559,037 | 435.6 K to 559 K (+28.35 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,835 | 0 | 473,231 | 470.4 K to 473.2 K (+0.60 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,835 | 0 | 474,194 | 471.4 K to 474.2 K (+0.60 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,025 | 0 | 338,154 | 336.1 K to 338.2 K (+0.60 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 123,476 | 0 | 336,129 | 212.7 K to 336.1 K (+58.06 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 20,250 | 0 | 3,782,354 | 3.8 M to 3.8 M (+0.54 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,234,757 | 0 | 3,762,104 | 2.5 M to 3.8 M (+48.86 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 20,250 | 0 | 3,541,315 | 3.5 M to 3.5 M (+0.58 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,234,757 | 0 | 3,521,065 | 2.3 M to 3.5 M (+54.01 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 113,716 | 0 | 18,313,582 | 18.2 M to 18.3 M (+0.62 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 4,682,816 | 0 | 18,199,866 | 13.5 M to 18.2 M (+34.64 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Sell | J | 0.00 | 243,001 | 0 | 0 | 243 K to 0 (-100.00 %) |
Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Sell | J | 0.00 | 13,340,645 | 0 | 0 | 13.3 M to 0 (-100.00 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 122 | 0 | 11,917 | 11.8 K to 11.9 K (+1.03 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 10,358 | 0 | 10,358 | 0 to 10.4 K |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 242 | 0 | 44,543 | 44.3 K to 44.5 K (+0.55 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 20,712 | 0 | 44,301 | 23.6 K to 44.3 K (+87.80 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 20,712 | 0 | 20,712 | 0 to 20.7 K |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 242 | 0 | 23,831 | 23.6 K to 23.8 K (+1.03 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 24 | 0 | 5,866 | 5.8 K to 5.9 K (+0.41 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 3,328 | 0 | 5,842 | 2.5 K to 5.8 K (+132.38 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 121 | 0 | 15,939 | 15.8 K to 15.9 K (+0.76 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 152 | 0 | 17,758 | 17.6 K to 17.8 K (+0.86 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 42 | 0 | 4,583 | 4.5 K to 4.6 K (+0.92 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 1,848 | 0 | 4,541 | 2.7 K to 4.5 K (+68.62 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 42 | 0 | 3,204 | 3.2 K to 3.2 K (+1.33 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 42 | 0 | 3,189 | 3.1 K to 3.2 K (+1.33 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 30 | 0 | 3,831 | 3.8 K to 3.8 K (+0.79 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 1,848 | 0 | 3,801 | 2 K to 3.8 K (+94.62 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 303 | 0 | 40,540 | 40.2 K to 40.5 K (+0.75 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 18,482 | 0 | 40,237 | 21.8 K to 40.2 K (+84.96 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 303 | 0 | 37,367 | 37.1 K to 37.4 K (+0.82 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 18,482 | 0 | 37,064 | 18.6 K to 37.1 K (+99.46 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 1,704 | 0 | 318,199 | 316.5 K to 318.2 K (+0.54 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | J | 0.00 | 70,092 | 0 | 316,495 | 246.4 K to 316.5 K (+28.45 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Sell | J | 0.00 | 3,637 | 0 | 0 | 3.6 K to 0 (-100.00 %) |
Dec 21 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Sell | J | 0.00 | 199,682 | 0 | 0 | 199.7 K to 0 (-100.00 %) |
Sep 28 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Option Exercise | A | 0.00 | 53,571 | 0 | 53,571 | |
Sep 28 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Option Exercise | A | 3.50 | 74,656 | 261,296 | 74,656 | |
Sep 28 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Grant | A | 3.50 | 21,428 | 74,998 | 13,517,050 | 13.5 M to 13.5 M (+0.16 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 1,664 | 7,089 | 220,123 | 218.5 K to 220.1 K (+0.76 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 3,355 | 15,098 | 218,459 | 215.1 K to 218.5 K (+1.56 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 1,993 | 8,490 | 212,653 | 210.7 K to 212.7 K (+0.95 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 4,018 | 18,081 | 210,660 | 206.6 K to 210.7 K (+1.94 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 10,779 | 45,919 | 435,561 | 424.8 K to 435.6 K (+2.54 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 21,741 | 97,835 | 424,782 | 403 K to 424.8 K (+5.39 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 8,952 | 38,136 | 1,562,083 | 1.6 M to 1.6 M (+0.58 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 18,054 | 81,243 | 1,553,131 | 1.5 M to 1.6 M (+1.18 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 30,514 | 129,990 | 2,527,347 | 2.5 M to 2.5 M (+1.22 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 61,544 | 276,948 | 2,496,833 | 2.4 M to 2.5 M (+2.53 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 10,792 | 45,974 | 470,396 | 459.6 K to 470.4 K (+2.35 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 21,765 | 97,943 | 459,604 | 437.8 K to 459.6 K (+4.97 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 16,824 | 71,670 | 1,581,431 | 1.6 M to 1.6 M (+1.08 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 33,934 | 152,703 | 1,564,607 | 1.5 M to 1.6 M (+2.22 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 29,652 | 126,318 | 2,286,308 | 2.3 M to 2.3 M (+1.31 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 59,806 | 269,127 | 2,256,656 | 2.2 M to 2.3 M (+2.72 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 10,775 | 45,902 | 471,359 | 460.6 K to 471.4 K (+2.34 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 21,733 | 97,799 | 460,584 | 438.9 K to 460.6 K (+4.95 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 278,921 | 1,188,203 | 13,495,622 | 13.2 M to 13.5 M (+2.11 %) |
Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 562,568 | 2,531,556 | 13,216,701 | 12.7 M to 13.2 M (+4.45 %) |
Aug 13 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Buy | P | 2.50 | 4,000,000 | 10,000,000 | 9,175,000 | 5.2 M to 9.2 M (+77.29 %) |
May 18 2020 | AQB | AquaBounty Technol ... | KIRK RANDAL J | 10% Owner | Option Exercise | A | 2.32 | 2,000 | 4,640 | 2,000 | |
Apr 02 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Grant | A | 2.61 | 76,628 | 199,999 | 10,588,601 | 10.5 M to 10.6 M (+0.73 %) |
Mar 20 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 2.72 | 420,336 | 1,143,314 | 10,511,973 | 10.1 M to 10.5 M (+4.17 %) |
Mar 20 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 2.05 | 79,664 | 163,311 | 10,091,637 | 10 M to 10.1 M (+0.80 %) |
Mar 20 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 1.87 | 500,000 | 935,000 | 10,011,973 | 9.5 M to 10 M (+5.26 %) |
Mar 20 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 2.72 | 420,336 | 1,143,314 | 10,511,973 | 10.1 M to 10.5 M (+4.17 %) |
Mar 20 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 2.05 | 79,664 | 163,311 | 10,091,637 | 10 M to 10.1 M (+0.80 %) |
Mar 20 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 1.87 | 500,000 | 935,000 | 10,011,973 | 9.5 M to 10 M (+5.26 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 24,787 | 145,252 | 182,200 | 157.4 K to 182.2 K (+15.75 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 29,684 | 173,948 | 151,802 | 122.1 K to 151.8 K (+24.31 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 160,606 | 941,151 | 337,234 | 176.6 K to 337.2 K (+90.93 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 133,370 | 781,548 | 1,299,267 | 1.2 M to 1.3 M (+11.44 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 454,642 | 2,664,202 | 1,832,054 | 1.4 M to 1.8 M (+33.01 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 160,785 | 942,200 | 366,548 | 205.8 K to 366.5 K (+78.14 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 250,674 | 1,468,950 | 1,316,798 | 1.1 M to 1.3 M (+23.51 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 441,800 | 2,588,948 | 1,675,873 | 1.2 M to 1.7 M (+35.80 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 160,546 | 940,800 | 367,560 | 207 K to 367.6 K (+77.55 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 5.86 | 4,155,802 | 24,353,000 | 22,684,644 | 18.5 M to 22.7 M (+22.43 %) |
Feb 04 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Grant | A | 6.02 | 33,223 | 200,002 | 18,528,842 | 18.5 M to 18.5 M (+0.18 %) |
Jan 07 2020 | XON | INTREXON CORP | KIRK RANDAL J | Executive Chairman | Option Exercise | M | 0.00 | 3,443 | 0 | 10,332 | |
Jan 07 2020 | XON | INTREXON CORP | KIRK RANDAL J | Executive Chairman | Buy | M | 0.00 | 3,443 | 0 | 18,495,619 | 18.5 M to 18.5 M (+0.02 %) |
Jan 02 2020 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.66 | 141,445 | 800,579 | 3,188,586 | 3 M to 3.2 M (+4.64 %) |
Jan 02 2020 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.81 | 34,434 | 200,062 | 18,492,176 | 18.5 M to 18.5 M (+0.19 %) |
Jan 02 2020 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.66 | 141,445 | 800,579 | 3,188,586 | 3 M to 3.2 M (+4.64 %) |
Jan 02 2020 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.81 | 34,434 | 200,062 | 18,492,176 | 18.5 M to 18.5 M (+0.19 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 1,161 | 0 | 0 | |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 1,746 | 0 | 0 | |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 3 | 0 | 0 | |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 106 | 0 | 0 | |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 539,337 | 1,618,011 | 0 | 539.3 K to 0 (-100.00 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 112,617 | 0 | 539,337 | 426.7 K to 539.3 K (+26.39 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 1,324,328 | 3,972,984 | 0 | 1.3 M to 0 (-100.00 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 169,602 | 0 | 1,324,328 | 1.2 M to 1.3 M (+14.69 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 2,453 | 7,359 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 291 | 0 | 2,453 | 2.2 K to 2.5 K (+13.46 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 80,160 | 240,480 | 0 | 80.2 K to 0 (-100.00 %) |
Dec 17 2019 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 10,282 | 0 | 80,160 | 69.9 K to 80.2 K (+14.71 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 1,161 | 0 | 0 | |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 1,746 | 0 | 0 | |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 3 | 0 | 0 | |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 106 | 0 | 0 | |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 539,337 | 1,618,011 | 0 | 539.3 K to 0 (-100.00 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 112,617 | 0 | 539,337 | 426.7 K to 539.3 K (+26.39 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 1,324,328 | 3,972,984 | 0 | 1.3 M to 0 (-100.00 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 169,602 | 0 | 1,324,328 | 1.2 M to 1.3 M (+14.69 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 2,453 | 7,359 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 291 | 0 | 2,453 | 2.2 K to 2.5 K (+13.46 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Sell | U | 3.00 | 80,160 | 240,480 | 0 | 80.2 K to 0 (-100.00 %) |
Dec 17 2019 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 10,282 | 0 | 80,160 | 69.9 K to 80.2 K (+14.71 %) |
Dec 03 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.35 | 149,543 | 800,055 | 3,047,141 | 2.9 M to 3 M (+5.16 %) |
Dec 03 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.63 | 35,536 | 200,068 | 18,457,742 | 18.4 M to 18.5 M (+0.19 %) |
Nov 01 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.94 | 134,628 | 799,690 | 2,897,598 | 2.8 M to 2.9 M (+4.87 %) |
Nov 01 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.54 | 36,069 | 199,822 | 18,422,206 | 18.4 M to 18.4 M (+0.20 %) |
Oct 01 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 6.12 | 130,761 | 800,257 | 2,762,970 | 2.6 M to 2.8 M (+4.97 %) |
Oct 01 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 6.12 | 130,761 | 800,257 | 2,762,970 | 2.6 M to 2.8 M (+4.97 %) |
Oct 01 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.99 | 33,373 | 199,904 | 18,386,137 | 18.4 M to 18.4 M (+0.18 %) |
Oct 01 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.99 | 33,373 | 199,904 | 18,386,137 | 18.4 M to 18.4 M (+0.18 %) |
Sep 03 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 7.46 | 107,265 | 800,197 | 2,632,209 | 2.5 M to 2.6 M (+4.25 %) |
Sep 03 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 6.65 | 30,088 | 200,085 | 18,352,764 | 18.3 M to 18.4 M (+0.16 %) |
Aug 02 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 7.81 | 102,477 | 800,345 | 2,524,944 | 2.4 M to 2.5 M (+4.23 %) |
Aug 02 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 7.76 | 25,758 | 199,882 | 18,322,676 | 18.3 M to 18.3 M (+0.14 %) |
Jul 02 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.46 | 146,487 | 799,819 | 2,422,517 | 2.3 M to 2.4 M (+6.44 %) |
Jul 02 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 5.46 | 146,487 | 799,819 | 2,422,517 | 2.3 M to 2.4 M (+6.44 %) |
Jul 02 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 7.03 | 28,467 | 200,123 | 18,296,918 | 18.3 M to 18.3 M (+0.16 %) |
Jul 02 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 7.03 | 28,467 | 200,123 | 18,296,918 | 18.3 M to 18.3 M (+0.16 %) |
Jun 10 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 5.26 | 29,647 | 155,943 | 1,142,758 | 1.1 M to 1.1 M (+2.66 %) |
Jun 10 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 5.23 | 34,788 | 181,941 | 1,113,111 | 1.1 M to 1.1 M (+3.23 %) |
Jun 10 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 5.26 | 59,295 | 311,892 | 975,084 | 915.8 K to 975.1 K (+6.47 %) |
Jun 10 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 5.23 | 69,577 | 363,888 | 915,789 | 846.2 K to 915.8 K (+8.22 %) |
Jun 10 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 5.26 | 59,295 | 311,892 | 975,084 | 915.8 K to 975.1 K (+6.47 %) |
Jun 10 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 5.23 | 69,577 | 363,888 | 915,789 | 846.2 K to 915.8 K (+8.22 %) |
Jun 10 2019 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 5.26 | 1,201 | 6,317 | 157,413 | 156.2 K to 157.4 K (+0.77 %) |